256 related articles for article (PubMed ID: 21707496)
1. Clinical development of experimental virus-mediated gene therapy for malignant glioma.
Rainov NG; Heidecke V
Anticancer Agents Med Chem; 2011 Oct; 11(8):739-47. PubMed ID: 21707496
[TBL] [Abstract][Full Text] [Related]
2. Novel therapies for malignant gliomas: a local affair?
Rainov NG; Söling A; Heidecke V
Neurosurg Focus; 2006 Apr; 20(4):E9. PubMed ID: 16709040
[TBL] [Abstract][Full Text] [Related]
3. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for human malignant brain tumors.
Rainov NG; Ren H
Cancer J; 2003; 9(3):180-8. PubMed ID: 12952303
[TBL] [Abstract][Full Text] [Related]
5. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for high grade gliomas.
Alavi JB; Eck SL
Expert Opin Biol Ther; 2001 Mar; 1(2):239-52. PubMed ID: 11727533
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic viruses for treatment of malignant brain tumours.
Rainov NG; Ren H
Acta Neurochir Suppl; 2003; 88():113-23. PubMed ID: 14531569
[TBL] [Abstract][Full Text] [Related]
8. Clinical development of experimental therapies for malignant glioma.
Rainov NG; Heidecke V
Sultan Qaboos Univ Med J; 2011 Feb; 11(1):5-28. PubMed ID: 21509204
[TBL] [Abstract][Full Text] [Related]
9. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.
Andreansky SS; He B; Gillespie GY; Soroceanu L; Markert J; Chou J; Roizman B; Whitley RJ
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11313-8. PubMed ID: 8876132
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials with retrovirus mediated gene therapy--what have we learned?
Rainov NG; Ren H
J Neurooncol; 2003 Dec; 65(3):227-36. PubMed ID: 14682373
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.
Shah AC; Benos D; Gillespie GY; Markert JM
J Neurooncol; 2003 Dec; 65(3):203-26. PubMed ID: 14682372
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for high-grade glioma.
Iwami K; Natsume A; Wakabayashi T
Neurol Med Chir (Tokyo); 2010; 50(9):727-36. PubMed ID: 20885107
[TBL] [Abstract][Full Text] [Related]
13. Conditionally replicative adenoviral vectors for malignant glioma.
Sonabend AM; Ulasov IV; Lesniak MS
Rev Med Virol; 2006; 16(2):99-115. PubMed ID: 16416455
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials of viral therapy for malignant gliomas.
Piccioni DE; Kesari S
Expert Rev Anticancer Ther; 2013 Nov; 13(11):1297-305. PubMed ID: 24138481
[TBL] [Abstract][Full Text] [Related]
15. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
Sandmair AM; Loimas S; Puranen P; Immonen A; Kossila M; Puranen M; Hurskainen H; Tyynelä K; Turunen M; Vanninen R; Lehtolainen P; Paljärvi L; Johansson R; Vapalahti M; Ylä-Herttuala S
Hum Gene Ther; 2000 Nov; 11(16):2197-205. PubMed ID: 11084677
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.
Ji N; Weng D; Liu C; Gu Z; Chen S; Guo Y; Fan Z; Wang X; Chen J; Zhao Y; Zhou J; Wang J; Ma D; Li N
Oncotarget; 2016 Jan; 7(4):4369-78. PubMed ID: 26716896
[TBL] [Abstract][Full Text] [Related]
17. Experimental therapies: gene therapies and oncolytic viruses.
Hulou MM; Cho CF; Chiocca EA; Bjerkvig R
Handb Clin Neurol; 2016; 134():183-97. PubMed ID: 26948355
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic viral therapy of malignant glioma.
Parker JN; Bauer DF; Cody JJ; Markert JM
Neurotherapeutics; 2009 Jul; 6(3):558-69. PubMed ID: 19560745
[TBL] [Abstract][Full Text] [Related]
19. Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.
Ikeda K; Wakimoto H; Ichikawa T; Jhung S; Hochberg FH; Louis DN; Chiocca EA
J Virol; 2000 May; 74(10):4765-75. PubMed ID: 10775615
[TBL] [Abstract][Full Text] [Related]
20. Vector therapies for malignant glioma: shifting the clinical paradigm.
Tyler MA; Sonabend AM; Ulasov IV; Lesniak MS
Expert Opin Drug Deliv; 2008 Apr; 5(4):445-58. PubMed ID: 18426385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
